Inoculated rats and age matched controls were maintained under the same conditions, with free access to food and water. The development of arthritis was assessed by measuring the hindpaw volume distal to the ankle joint using a plethysmograph (Volume-meter, MK-500, Muromachi Kikai Co, Kanagawa). Polyarthritis developed eight to 10 days after bacterial inoculation. When the hindpaw volume reached a plateau (about 10 days after the development of arthritis), rats with arthritis and control rats were killed for study in the following experiments.
BIOCHEMICAL MEASUREMENTS Serum concentrations of calcium, phosphorus, and alkaline phosphatase were measured using an autoanalyser (RX-40 Model, Nihon Denshi Inc Ltd). The serum osteocalcin concentration was determined by radioimmunoassay using a specific antibody against rat osteocalcin (Biochemical Technologies Inc, Stoughton, MA).
BONE MARROW PREPARATION
All procedures were performed under sterile conditions. Bilateral femora, tibiae, and humeri were resected and the epiphyseal ends of the bones removed. Bone marrow was flushed out into 15 ml conical culture tubes using 1 ml of a-minimum essential medium (aMEM) (Gibco BRL, Life Technologies Inc, Grand Island, NY) for each bone. The harvested marrow was filtered through a stainless steel mesh (50 ,um pore size) and centrifuged at 250 g for five minutes. The resulting supernatant was passed through a filter with 0-22 ,um pores and stored at -80°C. The cell pellet was resuspended in fresh aMEM and the number of viable cells counted in a haemocytometer using the trypan blue dye exclusion technique. The total number of bone marrow cells from AIA rat femur was similar to that from control rat femur (3.7 X 107/bone v 3-6 X 107/bone). The total number of tibial bone marrow cells was slightly increased in AIA rats (right tibia 3-1 x 107/bone, left tibia 2-6 X 107fbone) compared with the control group (2-4 X 107/bone), though not significantly. Cells were grown in aMEM supplemented with 15% fetal bovine serum (FBS) and a 1% penicillin-streptomycin mixture under an atmosphere of 5% carbon dioxide. The medium was changed completely after the first 24 hours of culture and every three days thereafter. The cells attached and grew to form FCFU colonies, were fixed in 2% glutaraldehyde or citrate-acetone-formaldehyde, and were stained with Wright-Giemsa stain or for alkaline phosphatase activity (Sigma kit, Sigma Chemical Co). The total number of FCFUs which contained a minimum of 50 cells were counted, as were the number of alkaline phosphatase positive FCFU with 50 or more cells.
OSTEOCLAST-LIKE CELLS IN BONE MARROW CULTURE
Bone marrow cells were plated in four well Lab Tek chamber slides (Nunc Inc, Naperville, IL) at a density of 1 X 106/ml, and were incubated in aMEM with 15% FBS and antibiotics. Culture was performed in the presence or absence of marrow supernatant to test the effect of marrow humoral factors on the induction of osteoclast-like cells. The medium was changed every three days and marrow supernatant was added at the time of medium change. Cells which showed attachment were fixed in citrate-acetone-formaldehyde and stained for tartrate resistant acid phosphatase (TRAP) activity (Sigma Kit, Sigma Chemical Co). TRAP positive cells which contained three or more nuclei were counted microscopically as osteoclast-like cells.
PIT FORMATION ASSAY Circular slices of ivory (6 mm diameter) were prepared using a bone slicer and an office paper punch. The slices were sonicated and sterilised in 70% ethanol, washed with aMEM, and each one placed in a well of a 96 well culture plate. Bone marrow cells were cultured in the presence of marrow supernatant for 12 days as described above, then plated onto the slices at a density of 2 X 106/well. The marrow cells were scraped with a rubber-policeman in 2 mol/l NaOH and the slices then stained with Coomassie Brilliant Blue. The pits (resorption lacunae) were counted microscopically.
NEUTRALISATION OF MARROW OSTEOCLAST-INDUCING ACTIVITY
To clarify the involvement of inflammatory cytokine(s) in bone marrow osteoclast-inducing activity, we used anti-IL-i and anti-TNF antibodies in a neutralisation study. These antibodies were a polyclonal rabbit antimurine IL-1 antibody (Genzyme C, Cambridge, MA) and a monoclonal hamster antimurine TNF antibody (2 mg/ml) (Genzyme), which could detect rat and mouse IL-ioa, and TNFax and TNF1, respectively. The anti-IL-i antibody inhibited concanavalin A stimulated rat spleen cell proliferation completely at a dilution of 1:50 and was used in the same dilution for the neutralisation study. The concentration of the anti-TNF antibody was 5 ,ug/ml. Rabbit IgG (Organon Teknika Co, Durham, NC) was used as a control. Bone marrow cells from normal rats were cultured in the presence of marrow supematant from rats with AIA, under the conditions described above.
EFFECT OF INFLAILMATORY CYTOKINES ON

FCFU
Five week old female DDY mice were used for this study. Recombinant human (rh) IL-1, (Otsuka Pharmaceutical Co, Osaka, Japan), rhTNFa (Dainippon Pharmaceutical Co, Osaka, Japan) and rhIL-6 (Genzyme) were given subcutaneously at a dose of 400-2000 U/day for seven days. The animals were then sacrificed, the femoral and tibial bone marrow cultured for seven days, and the number of FCFU counted.
MEASUREMENT OF BONE MINERAL DENSITY
The femoral and tibial bone mineral densities were determined by dual energy x ray absorptiometry (DXA) using an Aloka DCS-600 (Aloka Co, Mitaka, Japan). The bone mineral density was measured at the proximal, mid, and distal portions of each bone. The number of FCFUs which developed in marrow cell cultures from rats with AIA was significantly fewer than those developing in control cultures (figs 1, 2), though the deficit of FCFU growth was less severe in marrow from the humerus compared with tibial and femoral marrow. In all groups, about 80% of the cells inoculated initially failed to adhere to the flasks after 24 hours. The size of the FCFUs was similar in all cultures, but differences in FCFU numbers were apparent as early as day 7 of culture. About 50% of the colonies became alkaline phosphatase positive on day 7 in both the control and arthritis groups, but the number of positive FCFU was fewer in the rats with arthritis (fig 1) . When marrow cells from control rats were cultured on ivory slices in the presence of control marrow supernatant, shallow resorption lacunae (pits) were observed on the surface of the slices. Formation of pits was increased in the marrow cultures from rats with AIA, especially from the right tibia (inoculated side). When the marrow supematants from AIA rats were added to the control culture, a marked increase in the number of pits was observed (figs 4, 5). The number of pits on the ivory slices correlated significantly with the number of osteoclast-like cells generated on the chamber slides (r= 0-563, p < 0 01).
NEUTRALISATION OF OSTEOCLAST-INDUCING ACTIVITY
When bone marrow cells from control rats were cultured in the presence of femoral and tibial marrow supematant from rats with arthritis, the formation of osteoclast-like cells increased markedly. This increase in osteoclastlike cell formation was suppressed significantly by addition of the anti-IL-i antibody, compared with no antibody or addition of control rabbit IgG (fig 6) . The increase in osteoclastlike cell formation associated with the presence of femoral bone marrow supematant from rats with arthritis was suppressed in addition by 4 anti-TNF antibody, but that associated with the presence of tibial marrow supernatant from AIA rats was not significantly suppressed by that antibody. obtained from sites adjacent to inflamed joints. This may reflect a decrease in the absolute number of FCFUs per bone in rats with arthritis, because the total numbers of bone marrow cells per bone were similar in both control and arthritis groups. As the number of FCFUs can be used as an indirect bioassay of osteogenic activity, our data suggest a local decrease in osteogenic potential in rats with adjuvant induced arthritis. The decreased serum concentration of osteocalcin in these rats is consistent with this conclusion. The systemic suppression of bone formation may occur by immobilisation and malnutrition in rats with arthritis. However, compared with the culture of bone marrow from humerus, the decrease in osteogenic precursor cell colonies was more evident in cultures of marrow from the tibia and femur, which were the bones adjacent to the site of arthritis. This finding suggests that the local effect of arthritis may be more important for the periarticular suppression of bone formation, though a systemic effect cannot be excluded. We also demonstrated that the systemic administration of rhIL-l 3 induced a marked suppression of osteogenic precursor cell colony formation in marrow cultures from normal animals. These data are supported by the finding that systemic administration of IL-1 induced a decrease in serum osteocalcin concentration in rats. '9 In addition, an in vitro inhibitory effect of IL-I on bone formation has been reported.20 As IL-1 induces other inflammatory cytokines, such as IL-6, TNFat, and IL-8, these cytokines could also be involved in the decrease in marrow osteogenic precursor cell colony formation. However, our administration of TNFot or IL-6 did not induce any significant suppression of colony formation, suggesting that IL-1 might be the most important cytokine, at least in our experimental system.
Osteoclast-like cells differentiate from bone marrow derived macrophages in the presence of osteotrophic hormones in vitro. In previous studies, no significant formation of osteoclastlike cells from bone marrow cells was observed in the absence of inductive substances such as hormones, cytokines, or prostaglandins. In the present study, a very small number of osteoclast-like cells was generated in cultures of normal marrow without any inducers. However, bone marrow from rats with AIA formed a significantly larger number of osteoclast-like cells, although the number was still small. These findings might be explained by an increased number of osteoclast precursors in the bone marrow of rats with arthritis.
Several local factors have been suggested to have a role in the regulation of osteoclast maturation and activation. They include cytokines, prostaglandins, colony stimulating factors, and osteoblast derived soluble factor(s).-" 21 22 In the present study, addition of normal bone marrow supematant caused significant formation of osteoclast-like cells and resorption pits on the ivory slices in normal marrow cultures. This suggested the presence of some osteoclast inducing factor in the normal marrow supernatant. Increased formation of osteoclast-like cells and resorption pits in the culture of tibial bone marrow from AIA rats indicates that bone resorbing activity was increased in the bone marrow adjacent to the site of arthritis. In addition, marked stimulation of osteoclast-like cell and pit formation was observed when marrow supematant from AIA rats was added to the normal marrow culture. This suggested an increase in osteoclast inducing factor in AIA bone marrow. Although it is not clear if the same factors were responsible for the induction of osteoclast-like cells by normal and AIA marrow supematant, the results of our study suggested that one of the factors present in arthritis bone marrow was IL-1. Other cytokines or growth factors may be involved in osteoclast induction by marrow supematants, because anti-TNF antibody decreased the osteoclast inducing activity in the femoral bone marrow from AIA rats. As inflamed rheumatoid synovium produces IL-1, IL-6, and prostaglandins,2"25 the increase in IL-1 in the bone marrow might be the result of its diffusion from the adjacent inflamed joints. However, we cannot exclude the possibility that these bone marrow changes are a primary event.
Measurement of bone mineral density demonstrated localised bone loss in the periarticular regions of bilateral femur and tibia. However, the decrease in the distal portion of the tibia was rather small, possibly because of sclerotic changes induced by severe arthritis of the hind foot.
In conclusion, both a local decrease in osteogenic potential and accelerated bone resorption, partly mediated through an increase in IL-1 in the bone marrow, may be involved in the development of periarticular osteopenia associated with adjuvant induced arthritis. Accordingly, strategies aimed at decreasing IL-1 production may help to control such osteopenia. In addition, the role of other cytokines such as IL-6, and that of colony stimulating factors and chemical mediators in the pathogenesis of periarticular osteopenia requires clarification. 
